Drugs / synbiotic
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05576818 Comparator | Jun 2022 → Jun 2025 overdue | Parkinson disease | Tanta University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | synbiotic | “Hence, this study investigates the therapeutic potential of a synbiotic supplement, in conjunction with L-dopa for the management of PD.” PMID 40434674 ↗ May 2025 |
| Modality | Other / unclassified | “synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers” NCT05576818 ↗ |